JHTV
@JHTechVentures
JHTV brings the benefits of discovery to the world. Contact us! #Entrepreneurship #Innovation #StartUps RTs & links are not endorsements or warranties.
Our #JHTV team is volunteering with Moveable Feast, helping prepare medically tailored meals for Marylanders living with chronic illness and food insecurity. Each month, dozens of volunteers support this mission, and you can too. Volunteer today: buff.ly/gHbO6tE




We’ve launched the JHU Investor Hub! Explore startups from @JohnsHopkins that are actively raising funds—view pitch decks, raise info & more. Dive in: buff.ly/0L4m6Je For intros, contact Kayla Pindell: [email protected]

The Termeer Scholars Program relaunched its 2-day immersive experience, which will take place in Boston. If you're a postdoc, faculty member, or physician-scientist with a vision to improve patient outcomes, this program is for you. Apply by Aug 29: termeerinstitute.org/scholars/
New for JHU researchers: "Intro to Intellectual Property" — a free, self-paced course from JHTV + the @JohnsHopkins Provost’s Office via LAD Academy! Designed for faculty, open to all with JHED, learn IP basics + research commercialization Enroll today! buff.ly/kbtzCqe

Big win for Infinity Bio, Inc., a @JohnsHopkins-founded startup that raised $8M Series A to scale their immune profiling tech. Backed by @illuminaventure, @ptxcap, Blackbird Labs, + the Propel Baltimore Fund, they lead precision medicine & omics buff.ly/mQ8SKSm

The Smart Tissue Autonomous Robot (STAR), developed at @JohnsHopkins, performed the first autonomous soft-tissue laparoscopic surgery without any human guidance. It outperformed human surgeons in precision & consistency. Learn more: buff.ly/h76XGqR

Two JHTV colleagues, Liz Burger and Guido Galvez, received the Annual R. Keith Baker Award, honoring the late R. Keith Baker. The award recognizes his values: scientific curiosity, mentorship, altruism, calm leadership, perseverance, and dedication to Johns Hopkins.

10 years – that’s a wrap! Watch our final installment of a celebration of the last decade, a 4-minute video on how research commercialization took us from $17M to $100M in revenue. Featuring Christy Wyskiel and cancer genomics pioneer Bert Vogelstein: buff.ly/LVZBVVb

65+ student-led ventures completed the Pava Center's Kindling, Spark & Fuel accelerators, its largest cohort yet. From AI cancer screening to inclusive gaming, these teams are building the future with $100K+ awarded in non-dilutive funding. Read more: buff.ly/76ZNlhy

Autoimmune diseases impact 58.5M+ U.S. adults—yet federal budget cuts are stalling critical research. @MaxKonigMD of @HopkinsMedicine shares his thoughts on how these cuts could delay life-saving therapies for lupus, RA, and more. Learn more: buff.ly/XxVxLPU

The Wilmer Eye Institute is one of @JohnsHopkins’ most prolific departments for patents, startup activity, and licensing revenue. Many exciting innovations are underway – from gene therapy for retinal disease to surgical tools and drug delivery techniques! buff.ly/dQCCWlB

Thank you to everyone who attended last week's networking breakfast at @IAmBiotech in Boston! With nearly 200 attendees, we celebrated @JohnsHopkins leadership in innovation and academic translation in biotech. Stay involved w/ JHTV's work: buff.ly/5CObAZz

Congrats to @InfinityBioInc, a biotech startup born from @JohnsHopkins research, which has closed an $8M Series A led by @illuminaventure. This funding fuels their mission to transform antibody reactome profiling & advance precision medicine. buff.ly/W5jf6lj
